PreprintCited by 42Treatment of Major DepressionAdvanced MRI Techniques and ApplicationsTryptophan and brain disorders

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Proton magnetic resonance spectroscopy of N-acetyl aspartate in first depressive episode and chronic major depressive disorder: a systematic review and meta-analysis

Open access
Saccaro, Luigi F., Tassone, Matteo, Tozzi, Francesca, Rutigliano, Grazia·2022·Journal of Affective Disorders

Preprint — published as 10.1016/j.jad.2024.03.150 · Paper page

Abstract

N-acetyl aspartate (NAA) is a marker of neuronal integrity and metabolism. Deficiency in neuronal plasticity and hypometabolism are implicated in the pathophysiology of Major Depressive Disorder (MDD). To test if cerebral NAA concentrations decrease progressively over the MDD course, we conducted a meta-analysis of Proton Magnetic Resonance Spectroscopy ( 1 H-MRS) studies comparing NAA concentrations in chronic MDD (cMDD) and first episode of depression (FED) to healthy controls. We searched Scopus® and Web of Knowledge □ using search terms related to depression and NAA. Hedges’ g was used as effect size measure, together with heterogeneity analyses, test of moderators and publication bias and quality assessment. The protocol is registered in PROSPERO (CRD42020221050). Sixty-two studies were included and meta-analyzed using a random-effect model for each brain region. NAA concentrations were significantly reduced in cMDD compared to healthy controls within the frontal lobe (n=26, Hedges’ g= -0.330, 95% CI -0.598 to -0.062; p= 0.018), the occipital lobe (n = 4, Hedges’ g= -0.677, 95% CI -1.013 to -0.341; p = 0.007), the thalamus (n= 4, Hedges’ g= -0.673, 95% CI -1.108 to -0.238; p = 0.016) and the frontal (n = 6, Hedges’ g= -0.471, 95% CI -0.891 to -0.052; p= 0.034) and periventricular white matter (n= 3, Hedges’ g= -0.478, 95% CI -0.938 to -0.018; p= 0.047). We highlighted a gap of knowledge regarding NAA levels in FED. Sensitivity analyses indicated that antidepressant treatment may reverse NAA alterations in the frontal lobe. Our findings are in line with previous evidence showing alterations in the aforementioned brain areas in MDD. Future studies should assess NAA alterations in the early stages of the illness and their longitudinal progression, also considering our preliminary results on the modifying effect of antidepressant treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2022.07.01.22277107

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 138

  1. 10.1016/S0140-6736(18)32203-7 · DOI · Paper page
  2. 2011, Phenomenological differences between acute and chronic forms of major depression in inpatients, Nord J Psychiatry, 65, 330, 10.3109/08039488.2011.552121 · DOI
  3. 2021, The neuroprogressive nature of major depressive disorder: evidence from an intrinsic connectome analysis, Translational Psychiatry, 11, 102, 10.1038/s41398-021-01227-8 · DOI
  4. 2013, Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder, J Affect Disord, 150, 344, 10.1016/j.jad.2013.04.016 · DOI · Paper page
  5. 10.1016/j.pop.2012.03.010 · DOI
  6. 10.2147/PPA.S29716 · DOI · Paper page
  7. 2020, Proton Magnetic Resonance Spectroscopy of N-acetyl Aspartate in Chronic Schizophrenia, First Episode of Psychosis and High-Risk of Psychosis: A Systematic Review and Meta-Analysis, Neurosci Biobehav Rev, 119, 255, 10.1016/j.neubiorev.2020.10.001 · DOI
  8. 2018, Neurochemical differences between bipolar disorder type I and II in superior temporal cortices: A proton magnetic resonance spectroscopy study, J Affect Disord, 235, 15, 10.1016/j.jad.2018.04.010 · DOI
  9. 2017, Metabolic alterations in generalised anxiety disorder: a review of proton magnetic resonance spectroscopic studies, Epidemiol Psychiatr Sci, 26, 587, 10.1017/S2045796017000361 · DOI
  10. Jenkinson M , Chappell M. Introduction to neuroimaging analysis: Oxford University Press; 2018.
  11. 10.1007/7854_2011_197 · DOI
  12. 10.1016/S0022-510X(00)00373-7 · DOI
  13. 10.1016/j.clineuro.2014.12.005 · DOI
  14. 2002, Proton MR spectroscopy of tumefactive demyelinating lesions, AJNR Am J Neuroradiol, 23, 1378
  15. 2016, A comprehensive analysis of metabolic changes in the salvaged penumbra, Neuroradiology, 58, 409, 10.1007/s00234-015-1638-x · DOI
  16. 10.1046/j.1471-4159.2001.00285.x · DOI
  17. 2018, Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI): An In Vivo Proton Magnetic Resonance Spectroscopy (1H-MRS) Study, Acad Radiol, 25, 1167, 10.1016/j.acra.2018.01.005 · DOI
  18. 10.1136/jnnp.2008.168393 · DOI
  19. 10.1007/0-387-30172-0_17 · DOI
  20. 10.1159/000017321 · DOI
  21. 10.1186/s12888-014-0321-9 · DOI
  22. 10.1016/j.euroneuro.2015.04.016 · DOI · Paper page
  23. 10.1016/j.pscychresns.2005.12.004 · DOI · Paper page
  24. 10.1016/j.jclinepi.2009.06.005 · DOI · Paper page
  25. 10.1016/S0006-3223(02)01785-7 · DOI · Paper page
  26. 10.1111/j.1745-6924.2008.00088.x · DOI · Paper page
  27. 10.1038/s41380-018-0252-9 · DOI · Paper page
  28. 10.1016/j.pscychresns.2008.07.001 · DOI
  29. 10.1007/s10654-010-9491-z · DOI · Paper page
  30. 10.1136/ebmental-2019-300117 · DOI · Paper page
  31. 2010, Outlier and influence diagnostics for meta-analysis, Res Synth Methods, 1, 112, 10.1002/jrsm.11 · DOI · Paper page
  32. Harrer M , Cuijpers P , Furukawa TA , Ebert DD . Doing Meta-Analysis with R: A Hands-On Guide. Boca Raton, FL and London: Chapmann & Hall/CRC [Internet]. 2021. · DOI · Paper page
  33. Harrer M , Cuijpers P , Furukawa TA , Ebert DD . Doing Meta-Analysis with R: A Hands-On Guide. Boca Raton, FL and London: Chapmann & Hall/CRC [Internet]. 2021. · DOI · Paper page
  34. Schwarzer G , Carpenter James R. , Rücker, Gerta . meta-analysis with R 2015. · DOI · Paper page
  35. 10.1002/sim.1186 · DOI · Paper page
  36. 2012, GOSH - a graphical display of study heterogeneity, Res Synth Methods, 3, 214, 10.1002/jrsm.1053 · DOI
  37. 10.1136/bmj.315.7109.629 · DOI · Paper page
  38. Schwarzer G , Carpenter JR , Rücker G. meta-analysis with R 2015. · DOI · Paper page
  39. 10.1176/appi.neuropsych.22.4.370 · DOI
  40. 2017, Frontal Cortex Myo-Inositol Is Associated with Sleep and Depression in Adolescents: A Proton Magnetic Resonance Spectroscopy Study, Neuropsychobiology, 75, 21, 10.1159/000478861 · DOI
  41. 2017, Neuroimaging of major depression in Parkinson’s disease: Cortical thickness, cortical and subcortical volume, and spectroscopy findings, J Psychiatr Res, 90, 40, 10.1016/j.jpsychires.2017.02.010 · DOI
  42. 10.1038/mp.2012.46 · DOI
  43. 2006, Effects of antidepressive therapy on auditory processing in severely depressed patients: a combined MRS and MEG study, J Psychiatr Res, 40, 293, 10.1016/j.jpsychires.2005.09.003 · DOI
  44. 2012, Distinct neurometabolic profiles are evident in the anterior cingulate of young people with major psychiatric disorders, Transl Psychiatry, 2, e110, 10.1038/tp.2012.35 · DOI
  45. 10.1016/j.pscychresns.2003.11.002 · DOI
  46. 2018, Left fimbria atrophy is associated with hippocampal metabolism in female major depressive disorder patients, Annu Int Conf IEEE Eng Med Biol Soc, 2018, 1136
  47. 10.1002/jmri.10400 · DOI
  48. 10.1038/sj.npp.1300085 · DOI
  49. 10.1111/j.1600-0447.2011.01766.x · DOI
  50. 2016, Effects of Creatine Monohydrate Augmentation on Brain Metabolic and Network Outcome Measures in Women With Major Depressive Disorder, Biol Psychiatry, 80, 439, 10.1016/j.biopsych.2015.11.027 · DOI · Paper page
  51. 10.1017/S1461145708009516 · DOI
  52. 2017, Glutamatergic and neural dysfunction in postpartum depression using magnetic resonance spectroscopy, Psychiatry Res Neuroimaging, 265, 18, 10.1016/j.pscychresns.2017.04.008 · DOI
  53. 10.1038/sj.npp.1301248 · DOI
  54. 10.1016/S0006-3223(99)00159-6 · DOI
  55. 2009, Effects of overnight sleep restriction on brain chemistry and mood in women with unipolar depression and healthy controls, J Psychiatry Neurosci, 34, 352
  56. 10.1016/j.pscychresns.2004.12.001 · DOI
  57. 10.1016/j.biopsych.2006.08.048 · DOI
  58. 10.1016/0278-5846(94)90115-5 · DOI · Paper page
  59. 10.1016/j.pscychresns.2009.01.003 · DOI
  60. 2012, Imaging changes in neural circuits in patients with depression using (1)H-magnetic resonance spectroscopy and diffusion tensor imaging, Neural Regen Res, 7, 1881
  61. 2014, Anterior cingulate cortex and cerebellar hemisphere neurometabolite changes in depression treatment: A 1H magnetic resonance spectroscopy study, Psychiatry Clin Neurosci, 68, 357, 10.1111/pcn.12138 · DOI
  62. 10.1016/j.biopsych.2005.02.027 · DOI
  63. 2013, Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden, J Psychiatry Neurosci, 38, 107, 10.1503/jpn.110185 · DOI · Paper page
  64. 10.1007/s00406-006-0680-4 · DOI
  65. 2013, Hippocampal correlates of depression in healthy elderly adults, Hippocampus, 23, 1137, 10.1002/hipo.22185 · DOI
  66. 10.1016/j.pnpbp.2005.08.017 · DOI
  67. 2003, Association between dorsolateral prefrontal N-acetyl aspartate and depression in chronic back pain: an in vivo proton magnetic resonance spectroscopy study, J Neural Transm (Vienna), 110, 287, 10.1007/s00702-002-0781-9 · DOI
  68. 10.1097/00004424-200307000-00004 · DOI
  69. 2015, Neurometabolic characteristics in the anterior cingulate gyrus of Alzheimer’s disease patients with depression: a (1)H magnetic resonance spectroscopy study, BMC Psychiatry, 15, 306, 10.1186/s12888-015-0691-7 · DOI
  70. 10.1007/s004060050017 · DOI
  71. 10.1016/j.biopsych.2005.05.017 · DOI
  72. 10.1001/archpsyc.64.2.193 · DOI · Paper page
  73. 2015, Spectroscopic markers of memory impairment, symptom severity and age of onset in older people with lifetime depression: Discrete roles of N-acetyl aspartate and glutamate, J Affect Disord, 183, 31, 10.1016/j.jad.2015.04.023 · DOI
  74. 2015, The correlation between biochemical abnormalities in frontal white matter, hippocampus and serum thyroid hormone levels in first-episode patients with major depressive disorder, J Affect Disord, 180, 162, 10.1016/j.jad.2015.04.005 · DOI
  75. Jollant F , Near J , Turecki G , Richard-Devantoy S. Spectroscopy markers of suicidal risk and mental pain in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2016. · DOI · Paper page
  76. 10.1148/radiol.2381041375 · DOI
  77. 2020, Altered neurometabolism in major depressive disorder: A whole brain (1)H-magnetic resonance spectroscopic imaging study at 3T, Prog Neuropsychopharmacol Biol Psychiatry, 101, 109916, 10.1016/j.pnpbp.2020.109916 · DOI
  78. 10.1111/j.1440-1819.2009.01951.x · DOI
  79. 2019, Magnetic resonance (MR) spectroscopic measurement of gamma-aminobutyric acid (GABA) in major depression before and after electroconvulsive therapy, Acta Neuropsychiatr, 31, 17, 10.1017/neu.2018.22 · DOI
  80. 2020, Value of magnetic resonance spectroscopy in geriatric patients with cognitive impairment, Egypt J Neurol Psychiatry Neurosurg, 56, 10, 10.1186/s41983-020-0147-y · DOI
  81. 10.1176/appi.ajp.159.4.630 · DOI
  82. 10.1016/j.jad.2014.08.001 · DOI
  83. 2016, Evaluating metabolites in patients with major depressive disorder who received mindfulness-based cognitive therapy and healthy controls using short echo MRSI at 7 Tesla, MAGMA, 29, 523, 10.1007/s10334-016-0526-7 · DOI
  84. 2016, Differential neurometabolite alterations in brains of medication-free individuals with bipolar disorder and those with unipolar depression: a two-dimensional proton magnetic resonance spectroscopy study, Bipolar Disord, 18, 583, 10.1111/bdi.12445 · DOI
  85. 10.1177/0333102414557048 · DOI
  86. 2020, Serum copper and zinc levels correlate with biochemical metabolite ratios in the prefrontal cortex and lentiform nucleus of patients with major depressive disorder, Prog Neuropsychopharmacol Biol Psychiatry, 99, 109828, 10.1016/j.pnpbp.2019.109828 · DOI
  87. 2020, Correlations Among mRNA Expression Levels of ATP7A, Serum Ceruloplasmin Levels, and Neuronal Metabolism in Unmedicated Major Depressive Disorder, Int J Neuropsychopharmacol, 23, 642, 10.1093/ijnp/pyaa038 · DOI
  88. 10.1046/j.1468-1331.2003.00746.x · DOI
  89. 10.1038/npp.2012.101 · DOI
  90. 10.1016/j.biopsych.2010.08.009 · DOI
  91. 10.1017/S0033291799001567 · DOI
  92. 10.1017/S0033291703007931 · DOI
  93. 2009, Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study, Neuroimage, 47, 36, 10.1016/j.neuroimage.2009.03.031 · DOI
  94. 2007, Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: a pilot investigation comparing treatment responders and non-responders, Psychiatry Res, 156, 175, 10.1016/j.pscychresns.2007.04.002 · DOI
  95. 10.1016/j.pscychresns.2009.05.003 · DOI
  96. 2017, Neurochemical correlates of rapid treatment response to electroconvulsive therapy in patients with major depression, J Psychiatry Neurosci, 42, 6, 10.1503/jpn.150177 · DOI
  97. 10.1016/S0165-1781(03)00235-X · DOI
  98. 2020, Sex differences in brain metabolites in anxiety and mood disorders, Psychiatry Res Neuroimaging, 305, 111196, 10.1016/j.pscychresns.2020.111196 · DOI
  99. 10.1016/j.jpsychires.2010.08.010 · DOI · Paper page
  100. 10.1016/S0006-3223(96)00256-9 · DOI
  101. 10.1001/archpsyc.61.7.705 · DOI
  102. 2018, Correlations between working memory impairment and neurometabolites of prefrontal cortex and lenticular nucleus in patients with major depressive disorder, J Affect Disord, 227, 236, 10.1016/j.jad.2017.10.030 · DOI
  103. 2021, Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7T, J Affect Disord, 279, 417, 10.1016/j.jad.2020.10.011 · DOI
  104. 2013, Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression, Neuropsychiatr Dis Treat, 9, 1053
  105. 10.1177/0284185113502744 · DOI
  106. 10.1017/S1461145712000272 · DOI
  107. 2020, Proton magnetic resonance spectroscopic analysis of changes in brain metabolites following electroconvulsive therapy in patients with major depressive disorder, Int J Psychiatry Clin Pract, 24, 96, 10.1080/13651501.2019.1699118 · DOI
  108. 10.1016/S0006-3223(02)01908-X · DOI
  109. 2012, Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study, J Affect Disord, 136, 620, 10.1016/j.jad.2011.10.020 · DOI
  110. 2020, Intermittent theta-burst stimulation moderates interaction between increment of N-Acetyl-Aspartate in anterior cingulate and improvement of unipolar depression, Brain Stimul, 13, 943, 10.1016/j.brs.2020.03.015 · DOI
  111. 2015, A MRS study of metabolic alterations in the frontal white matter of major depressive disorder patients with the treatment of SSRIs, BMC Psychiatry, 15, 99, 10.1186/s12888-015-0489-7 · DOI
  112. 10.1016/j.jad.2014.07.024 · DOI
  113. 2020, Study on Dorsolateral Prefrontal Cortex Neurochemical Metabolite Levels of Patients with Major Depression Using H-MRS Technique, Turk Psikiyatri Derg, 31, 75
  114. 2012, Monoamine theories of depression: historical impact on biomedical research, J Hist Neurosci, 21, 366, 10.1080/0964704X.2011.623917 · DOI
  115. 10.1016/S0006-3223(00)00935-5 · DOI · Paper page
  116. 10.1073/pnas.95.22.13290 · DOI · Paper page
  117. 10.1016/j.jad.2008.04.027 · DOI · Paper page
  118. 2016, Functional alterations of fronto-limbic circuit and default mode network systems in first-episode, drug-naive patients with major depressive disorder: A meta-analysis of resting-state fMRI data, J Affect Disord, 206, 280, 10.1016/j.jad.2016.09.005 · DOI
  119. 2022, Aberrant pattern of cerebral blood flow in patients with major depressive disorder: A meta-analysis of arterial spin labelling studies, Psychiatry Research: Neuroimaging, 321, 111458, 10.1016/j.pscychresns.2022.111458 · DOI
  120. 10.1093/brain/awu072 · DOI
  121. 2021, Alterations in the Occipital Cortex of Drug-Naïve Adults With Major Depressive Disorder: A Surface-Based Analysis of Surface Area and Cortical Thickness, Psychiatry Investig, 18, 1025, 10.30773/pi.2021.0099 · DOI
  122. 2021, Abnormal neural activities in adults and youths with major depressive disorder during emotional processing: a meta-analysis, Brain Imaging Behav, 15, 1134, 10.1007/s11682-020-00299-2 · DOI · Paper page
  123. 2016, Essential brain structural alterations in major depressive disorder: A voxel-wise meta-analysis on first episode, medication-naive patients, J Affect Disord, 199, 114, 10.1016/j.jad.2016.04.001 · DOI · Paper page
  124. 10.1016/j.pnpbp.2011.09.014 · DOI · Paper page
  125. 10.1016/j.biopsych.2006.09.020 · DOI · Paper page
  126. 10.1176/appi.ajp.2012.11071105 · DOI · Paper page
  127. 2013, Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD, J Psychiatry Neurosci, 38, 49, 10.1503/jpn.110180 · DOI
  128. 2017, Subcortical volume and white matter integrity abnormalities in major depressive disorder: findings from UK Biobank imaging data, Sci Rep, 7, 5547, 10.1038/s41598-017-05507-6 · DOI
  129. 10.1016/j.copsyc.2014.12.011 · DOI · Paper page
  130. 10.1093/scan/nsq080 · DOI · Paper page
  131. 10.1016/j.jad.2009.01.034 · DOI · Paper page
  132. 10.1016/j.jad.2013.06.050 · DOI · Paper page
  133. 10.1016/j.biopsych.2005.04.035 · DOI · Paper page
  134. 2020, Rumination and the default mode network: Meta-analysis of brain imaging studies and implications for depression, Neuroimage, 206, 116287, 10.1016/j.neuroimage.2019.116287 · DOI · Paper page
  135. 2021, Mood disorders disrupt the functional dynamics, not spatial organization of brain resting state networks, Neuroimage Clin, 32, 102833, 10.1016/j.nicl.2021.102833 · DOI
  136. 10.1016/0022-2364(79)90019-2 · DOI
  137. 10.1002/mrm.1104 · DOI
  138. 2021, N-acetylaspartate concentration in psychotic disorders: T2-relaxation effects, Schizophr Res, 232, 42, 10.1016/j.schres.2021.04.012 · DOI

Metadata

Authors
Saccaro, L. F., Tassone, M., Tozzi, F., & Rutigliano, G.
Affiliations
  • University of Geneva (CH)
  • University of Pisa (IT)
  • Scuola Normale Superiore (IT)
Corresponding author
Saccaro, Luigi F.
Venue
Journal of Affective Disorders
Publisher
openRxiv
Published
2022-07-02
Volume
355
Pages
265-282
ISSN
0165-0327 (ISSN-L)
OpenAlex
W4393258906
Cited by
42
References
1
Citations by year
2026: 15 · 2025: 18 · 2024: 8 · 2023: 1
FWCI
2.57
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Affective Disorders (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • European Commission (HORIZON2020, 101026235)
  • Università di Pisa (Ateneo 2019)
  • HORIZON EUROPE Framework Programme
  • Horizon 2020
  • Marine Stewardship Council
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
N-acetylaspartate, major depressive disorder, first-episode depression, chronic depression, 1H NMR, brain metabolites, neuronal integrity, frontal lobe, occipital lobe, thalamus, white matter, antidepressant treatment, field strength
MeSH terms
Aspartic Acid, Brain, Chronic Disease, Major Depressive Disorder, Frontal Lobe, Humans, Occipital Lobe, Thalamus, White Matter, Proton Magnetic Resonance Spectroscopy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review